Aprecia Pharms patent expiration
1. Spritam patent expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US6471992 | APRECIA PHARMS | Dosage form exhibiting rapid disperse properties, methods of use and process for the manufacture of same |
Feb, 2018
(6 years ago) | |
| US9463160 | APRECIA PHARMS | Dosage form exhibiting rapid disperse properties, methods of use and process for the manufacture of same |
Feb, 2018
(6 years ago) | |
| US11160786 | APRECIA PHARMS | Rapid disperse dosage form |
Mar, 2034
(9 years from now) | |
| US9339489 | APRECIA PHARMS | Rapid disperse dosage form containing levetiracetam |
Mar, 2034
(9 years from now) | |
| US9669009 | APRECIA PHARMS | Rapid disperse dosage form containing levetiracetam |
Mar, 2034
(9 years from now) | |
Drugs and Companies using LEVETIRACETAM ingredient
Market Authorisation Date: 31 July, 2015
Treatment: Method of administering levetiracetam; Method of administering levetiracetam under fed conditions
Dosage: TABLET, FOR SUSPENSION
More Information on Dosage
SPRITAM family patents
